Original Research
Published on 24 Feb 2021
Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2020.603432
- 12,844 views
- 11 citations
